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ap1 and Ras are closely related GTPases that share
some effectors but have distinct functions. We studied
the subcellular localization of Rap1 and its sites of
activation in living cells. Both GFP-tagged Rap1 and endog-
enous Rap1 were localized to the plasma membrane (PM)
and endosomes. The PM association of GFP-Rap1 was
dependent on GTP binding, and GFP-Rap1 was rapidly
up-regulated on this compartment in response to mitogens,
a process blocked by inhibitors of endosome recycling. A
novel ﬂuorescent probe for GTP-bound Rap1 revealed that
R
 
this GTPase was transiently activated only on the PM of
both ﬁbroblasts and T cells. Activation on the PM was
blocked by inhibitors of endosome recycling. Moreover,
inhibition of endosome recycling blocked the ability of
Rap1 to promote integrin-mediated adhesion of T cells.
Thus, unlike Ras, the membrane localizations of Rap1 are
dynamically regulated, and the PM is the principle platform
from which Rap1 signaling emanates. These observations
may explain some of the biological differences between
these GTPases.
 
Introduction
 
The Ras superfamily of monomeric GTPases controls a wide
range of cellular processes. The prototypical member of this
class of regulatory molecules, Ras, plays a role in 
 
 
 
30% of
human cancers. Rap1 is a member of the subset of mono-
meric GTPases that are most closely related to Ras itself.
Whereas the biological functions of Ras, particularly its roles
in cellular growth and differentiation, are well established,
the functions of Rap1 are poorly understood. Originally
described as a suppressor of Ras-mediated oncogenic trans-
formation (Kitayama et al., 1989), one model held that
Rap1 functions by competing for Ras effectors, a view that
was supported by the ability of Rap1 to bind to Raf-1 but to
not activate the MAPK cascade (Bos, 1998). This view lost
some credence when it was reported that Rap1 can stimulate
MAPK through B-Raf (Vossler et al., 1997) and that overex-
pressed Rap1 was capable of inducing oncogenic transforma-
tion in Swiss 3T3 fibroblasts (Altschuler and Ribeiro-Neto,
1998). Other Ras effectors that promote cellular growth
(e.g., RalGDS) are also activated by interaction with Rap1
(Kishida et al., 1997).
Growth control is but one of a variety of processes in
which Rap1 has been implicated. The Rap1 guanine nucle-
otide exchange factor (GEF) Epac2 has been linked to
cAMP-regulated exocytosis, implicating Rap in the control
of vesicular trafficking (Ozaki et al., 2000). Overexpression
of Rap1 stimulated integrin-dependent adhesion of human
T cells, and adhesion of T cells was blocked by expression of
dominant-negative Rap1 (Reedquist et al., 2000). Particularly
illustrative of the distinct functions of Ras and Rap is the
recent finding that these GTPases have opposing effects on
AMPA receptor trafficking (Zhu et al., 2002).
The search for functions of Rap1 has included analyses in
lower eukaryotes. Bud1, a 
 
Saccharomyces cerevisiae
 
 orthologue
of Rap1, is critical for the establishment of yeast polarity
through the assembly of the actin cytoskeleton during bud
formation (Park et al., 1999). In 
 
Dictyostelium discoideum
 
,
membrane ruffling and lamellipodia formation, both actin-
based morphological changes, were regulated by Rap1
(Rebstein et al., 1997). In 
 
Drosophila melanogaster
 
,
 
 
 
the dis-
tribution of adherens junctions in epithelium is controlled by
an orthologue of Rap1 (Knox and Brown, 2002).
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The distinct functions of Ras and Rap1 suggest that de-
spite 70% sequence identity within the effector binding re-
gion, including complete identity among residues shown to
make contact with the Ras binding domain (RBD) of effec-
tors (Bos et al., 2001), these GTPases are differentially regu-
lated. Indeed, although some GEFs are shared between Ras
and Rap1 (e.g., Ras-GRP2), others are Rap1 specific (e.g.,
C3G; Bos et al., 2001). Once loaded with GTP, modulation
of the nucleotide binding state differs between Ras and Rap
because, unlike Ras and most Ras-related GTPases that have
a glutamine residue at position 61, Rap1 has a threonine and
therefore very low intrinsic GTPase activity. In addition to
this intrinsic difference, Rap1-specific GTPase activating
proteins (GAPs) have been described previously (Polakis et
al., 1991). Despite the similarities of the effector domains of
Ras and Rap1, particularly in the switch 1 domain, the rela-
tive affinities for effectors differs considerably, perhaps due
to differences in the switch 2 domain. For example, whereas
the RBD of Raf-1 binds to Ras with a 50-fold higher affinity
than to Rap1, the opposite is true for the RBD of RalGDS
(Herrmann et al., 1996).
Ras and Rap1 also differ in their COOH-terminal hyper-
variable regions that direct posttranslational modification
and membrane targeting. Whereas Ras proteins are modified
with a farnesyl isoprenoid, Rap1 is modified with a gera-
nylgeranyl lipid. Consistent with their distinct membrane-
targeting motifs, the subcellular localizations of Ras and
Rap1 have been reported to differ, a feature that could ex-
plain, in part, differential function. In primary myeloid cells,
Rap1, but not Ras, is associated with specialized vesicular
compartments that serve as pools of membrane that can be
rapidly mobilized to the cell surface during degranulation
(Maridonneau-Parini and de Gunzburg, 1992; Mollinedo et
al., 1993; Berger et al., 1994). Indirect immunofluorescence
analysis of cultured fibroblasts and epithelial cells has re-
vealed Rap1 in the Golgi region (Beranger et al., 1991) and
on endosomes (Pizon et al., 1994) but not on the plasma
membrane (PM). In contrast, in the same cells, Ras proteins
are expressed at steady state on both the PM and the Golgi
apparatus (Choy et al., 1999). Rap1, like Ras, has been
shown to undergo GTP/GDP exchange in response to vari-
ous growth factors (Zwartkruis et al., 1998). Using a fluores-
cent probe, we have recently determined that both the PM
and Golgi pool of Ras is activated as a consequence of
growth factor signaling (Chiu et al., 2002). Recent works
have examined the subcellular location of Rap signaling by
using a chimeric FRET-based GTPase sensor, Raichu-Rap1
(Mochizuki et al., 2001; Ohba et al., 2003). Despite its tar-
geting to the PM with the hypervariable region of K-Ras4B,
this probe reported activation of Rap1 on endomembranes
in living cells stimulated with EGF.
By analyzing GFP-tagged Rap1 proteins in living cells and
by localizing endogenous Rap1 using subcellular fraction-
ation, we found that the steady-state localization of Rap1 in-
cludes endosomes and the PM but not the Golgi apparatus,
that PM localization was dependent on GTP binding, and
that growth factors stimulated a rapid increase in Rap1 ex-
pression on the PM that was dependent on exocytosis. By
fusing GFP to the RBD of RalGDS (GFP-RBD
 
RalGDS
 
), we
have developed a Rap1-specific probe that has allowed us to
determine where and when Rap1 is activated in living cells.
We found that, in contrast to Ras (Chiu et al., 2002), only
the pool of Rap1 associated with the PM became activated
in response to growth factors. Similar results were obtained
in T cells in which Rap1-mediated adhesion was blocked by
inhibition of exocytosis.
 
Results
 
PM localization of GFP-Rap1 in living cells is 
nucleotide dependent
 
To determine the steady-state subcellular distribution of
Rap1 in living cells, we expressed the GTPase tagged at the
NH
 
2
 
 terminus with GFP in a variety of cell lines and ob-
served localization of the fusion protein by laser scanning
confocal microscopy. In both COS-1 and MDCK cells,
GFP-Rap1 was observed on the PM as well as on the nuclear
envelope and on cytoplasmic vesicles that were most abun-
dant in the paranuclear region (Fig. 1, A and B). In COS-1
cells, PM expression was most prominent on membrane ruf-
fles. To determine if the guanine nucleotide binding state of
Rap1 influences its subcellular localization, we tagged GTP-
bound (Rap1V12) and nucleotide-free (Rap1N17) mutants
with GFP. Whereas the GTP-bound form displayed a
steady-state localization indistinguishable from wild type,
the nucleotide-free form was observed on cytoplasmic vesi-
cles but not on the PM (Fig. 1, A and B). Thus, unlike GFP-
H-Ras (Chiu et al., 2002), the steady-state distribution of
Rap1 depends on its guanine nucleotide binding state.
Because Rap1 has been reported previously on endosomes
(Pizon et al., 1994), we tested whether the intracellular
vesicles that expressed GFP-Rap1 were derived from this
compartment. Both the peripheral and paranuclear vesicles
marked by GFP-Rap1 incorporated Texas-red–conjugated
transferrin and were therefore endosomal (Fig. 1 C). The in-
tracellular vesicles marked by GFP-Rap1V12 and GFP-
Rap1N17 also accumulated transferrin (Fig. 1 C). Thus, un-
like localization at the PM, the endosomal targeting of Rap1
does not depend on guanine nucleotide binding state.
In addition to endosomes, intracellular Rap1 has been
reported on the Golgi apparatus (Beranger et al., 1991).
To determine if Golgi membranes were a component of
the paranuclear compartment marked by GFP-Rap1, we co-
transfected cells with GFP-Rap1 and a Golgi marker,
CFP-tagged galactosyl transferase (CFP-GalT), and resolved
the two proteins by laser scanning confocal microscopy cou-
pled with spectral deconvolution. Although both proteins
were highly enriched in the paranuclear region where the
Golgi apparatus, the endosome recycling compartment, and
the microtubule organizing center are known to interdigi-
tate, GFP-Rap1 was not enriched on the structure clearly de-
lineated by CFP-GalT (Fig. 1 D). In contrast, GFP-N-Ras,
previously shown to reside on the Golgi apparatus and PM
(Choy et al., 1999), decorated the identical structures
marked by CFP-GalT (Fig. 1 E). Thus, unlike N-Ras, Rap1
is not enriched on the Golgi apparatus.
 
Endogenous Rap1 is expressed on the PM
 
To compare the localization of GFP-Rap1 with that of en-
dogenous Rap1, we analyzed a variety of cell lines for Rap1 
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using indirect immunofluorescence. We found that, unlike
the reproducible results obtained by imaging GFP-Rap1 in
living cells, the pattern of endogenous Rap1 revealed by in-
direct immunofluorescence was sensitive to fixation and per-
meabilization methods. In both COS-1 and MDCK cells,
the most reproducible pattern observed was one of widely
distributed cytoplasmic vesicles consistent with endosomes,
in agreement with Pizon et al. (1994). PM staining was
not  observed. However, cells transfected with GFP-Rap1
that—when imaged alive, revealed unambiguous PM local-
ization of the fusion protein—when fixed, permeabilized, and
stained for Rap1, revealed staining only on intracellular
membranes (unpublished data). This result suggests that ei-
ther indirect immunofluorescent staining with currently
available anti-Rap1 antibodies is not sensitive enough to de-
tect Rap1 at the PM or that fixation and permeabilization
leads to selective loss of the Rap1 protein or its relevant anti-
genic epitope at the PM. Accordingly, we analyzed the PM
for endogenous Rap1 using an independent method, subcel-
lular fractionation. Using a discontinuous sucrose density
gradient followed by a continuous Optiprep gradient, we
obtained fractions from homogenates of MDCK cells highly
enriched in membranes derived from the Golgi apparatus,
endosomes, and PM. Golgi, endosomal, and PM fractions
were highly enriched for galactosyl transferase, EEA-1, and
Na/K ATPase, respectively. Immunoreactive Rap1 was
present in both endosomal and PM fractions (Fig. 2). Im-
portantly, neither the Golgi complex nor PM fractions were
contaminated by EEA1-positive membranes. The trace
amount of immunoreactive Rap1 detected in Golgi fractions
was similar to levels of immunoreactive Na/K ATPase in
those fractions, supporting the conclusion that the small
amount of Rap1 detected in Golgi fractions could derive
from the inevitable contamination of Golgi membranes with
PM-derived vesicles. To further establish that endogenous
Rap1 was expressed on the PM, we used a well-characterized
method for the affinity purification of PM-derived vesicles.
COS-1 cells were biotinylated at 4
 
 
 
C to allow modification
only of surface membrane; after Dounce homogenization,
biotinylated vesicles were affinity purified using immobi-
lized streptavidin (Mammen et al., 1997). Rap1 was found
in the biotinylated fraction, which also contained Na/K ATP-
ase but not EEA-1 (Fig. 2, Biotin PM lane). Thus, the re-
sults from subcellular fractionation were concordant with
those obtained by localizing GFP-Rap1 in living cells. From
these data, we conclude that the localization of overex-
pressed GFP-Rap1 on both PM and endosomes reflects the
localization of the endogenous GTPase.
 
Mitogens induce rapid, exocytosis-dependent 
up-regulation of Rap1 on the PM
 
The localization of Rap1 on intracellular vesicles including
endosomes, as well as on the PM, raised the possibility that
PM-associated Rap1 might be regulated by exocytosis. In-
deed, Rap1 associated with intracellular granules of neutro-
phils (Maridonneau-Parini and de Gunzburg, 1992) and
Figure 1. Localization of GFP-Rap1 in living cells. COS-1 (A) or 
MDCK (B) cells were transfected with GFP-Rap1 (i), GFP-Rap1V12 
(ii), or GFP-Rap1N17 (iii) and imaged 24 h after transfection with a 
laser scanning confocal microscope. Results are representative of three 
independent experiments ( 30 cells examined per condition per 
experiment). (C) COS-1 cells were transfected as in A and incubated 
at 37 C for 30 min with Texas red–conjugated transferrin. Dual color 
confocal images were acquired showing colocalization in yellow. 
Enlarged inset in panel i shows transferrin in the lumen of endosomes 
decorated with GFP-Rap1. (D and E) COS-1 cells were cotransfected 
with CFP-GalT and either GFP-Rap1 (D) or GFP-N-Ras (E) and 
imaged with a laser scanning confocal microscope equipped with 
the Meta™ system of spectral deconvolution capable of separating 
CFP from GFP. Bars, 10  M.
Figure 2. Localization of endogenous Rap1. Subcellular fraction-
ation of MDCK cells using sucrose followed by Optiprep gradients 
or biotinylation cell surface expression assay. Immunoblot analysis 
for EEA1, Na/K ATPase, and Rap1 was performed on the total mem-
brane fraction (TM) and on membrane fractions highly enriched for 
the Golgi complex (Golgi), plasma membranes (PM), or endosomes 
(Endo) obtained by Optiprep, or on PM obtained by biotin affinity 
purification (Biotin PM). Results are representative of two indepen-
dent experiments. 
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platelets (Nagata and Nozawa, 1995) serves as a pool that
can be rapidly mobilized to the PM upon degranulation.
Therefore, we used GFP-Rap1 to determine if PM expres-
sion was rapidly modulated. In serum-starved COS-1 cells,
EGF stimulated up-regulation of PM-associated GFP-Rap1
(Fig. 3 A). The rapidity of this response (evident by 5 min)
was inconsistent with new synthesis of GFP-Rap1 and sug-
gested translocation from another compartment, in this case,
intracellular vesicles. To confirm that EGF-stimulated up-
regulation of PM-associated GFP-Rap1 was mediated by
exocytosis, we used 
 
N
 
-ethylmaleimide (NEM), a reagent
known to block a wide range of vesicular fusion events in-
cluding those associated with endocytic recycling (Galli et
al., 1994). Pretreatment of cells with NEM blocked EGF-
stimulated up-regulation of Rap1 on the PM (Fig. 3 A).
 
Among the various subclasses of endosomes, it is the recy-
cling endosomes that traffic to the cell surface and fuse with
the PM in an NEM-sensitive process (Galli et al., 1994).
Endosome recycling has been shown to be controlled by
Rab11 and negatively regulated by a dominant-negative
Rab11 binding protein (Rab11BP; Zeng et al., 1999). We
overexpressed dominant-negative Rab11BP with GFP-Rap1
and observed markedly decreased GFP-Rap1 at the PM at
baseline and inhibition of EGF-stimulated up-regulation of
GFP-Rap1 at the PM, confirming regulation of PM-associ-
ated Rap1 expression by endosomal recycling (Fig. 3 A). In
contrast to GFP-Rap1, GFP-H-Ras was expressed in serum-
starved cells on the PM and the Golgi apparatus, and the
distribution was not influenced by stimulation with EGF
(Fig. 3 B). Thus, as in hematopoetic cells, Rap1 is expressed
on the PM of fibroblasts and the extent of PM expression
can be rapidly up-regulated by exocytosis from a Rab11BP-
sensitive compartment.
 
Recruitment of GFP-RBD
 
RalGDS
 
 from the cytosol to 
membranes reports localization of GTP-bound Rap1
 
We have shown that the RBD of Raf-1 tagged with GFP is a
fluorescent probe that can report where and when Ras is acti-
vated in living cells without significant interaction with
GTP-bound Rap1 (Chiu et al., 2002). To develop an analo-
gous probe specific for Rap1, we used the RBD of RalGDS,
an effector for Ras and Rap1 that in contrast to Raf-1 has a
higher affinity for Rap1 (Herrmann et al., 1996). When ex-
pressed alone in serum-starved cells, GFP-RBD
 
RalGDS
 
 had a
homogeneous distribution in the cytosol and nucleoplasm re-
vealing negatively imaged organelles and accumulating on no
membrane compartment (Fig. 4 A, i). This pattern was indis-
tinguishable from that of GFP-RBD
 
Raf-1
 
 (Fig. 4 B, vi) or GFP
expressed alone in the same cells. However, when coex-
pressed with wild-type Rap1, GFP-RBD
 
RalGDS
 
 accumulated
on PM in peripheral ruffles (Fig. 4 A, ii). When coexpressed
with Rap1V12, the reporter accumulated on prominent PM
ruffles as well as on paranuclear vesicles (Fig. 4 A, iii). No
redistribution was observed when GFP-RBD
 
RalGDS
 
 was
coexpressed with nucleotide-free, dominant-negative Rap1N17
(Fig. 4 A, iv). Thus, membrane recruitment of GFP-
RBD
 
RalGDS
 
 was dependent on the GTP-bound state of Rap1.
Because in addition to Rap1, H-Ras, M-Ras, and R-Ras
may interact with the RBD of RalGDS (Ehrhardt et al.,
2002), we determined the specificity of membrane recruit-
ment of GFP-RBD
 
RalGDS
 
 for reporting GTP-bound Rap1.
We coexpressed the probe with GTP-bound H-Ras61L,
M-Ras71L, or R-Ras87L and observed no membrane re-
cruitment (Fig. 4 B, iii–v) in serum-starved COS-1 cells.
Conversely, GFP–RBD
 
Raf–1
 
 was a sensitive probe for GTP-
bound H-Ras61L, M-Ras71L, or R-Ras87L (Fig.4B, viii–x)
but not GTP-bound Rap1 (Fig. 4 B, vii). Moreover, domi-
nant-negative Rap1N17 blocked wild-type Rap1-mediated
recruitment of GFP-RBD
 
RalGDS
 
 to membrane ruffles (Fig. 4
C, i and ii). Thus, GFP-RBD
 
RalGDS
 
 is an in vivo probe spe-
cific for activated Rap1.
To validate GFP-RBD
 
RalGDS
 
 recruitment to membranes as
a readout of Rap1 activation and to confirm the PM lo-
calization of activated Rap1, we stimulated Rap1 via an al-
ternative, growth factor–independent pathway. Activated
Figure 3. Growth factor stimulates exocytosis-dependent up-
regulation of Rap1 on the PM. (A) COS-1 cells were transfected with 
GFP-Rap1 wild type without (top and middle) or with cotransfection 
of dominant-negative Rab11BP (bottom). Cells were serum starved 
24 h after transfection, stimulated with EGF in the absence (top and 
bottom) or presence (middle) of NEM, and imaged before and 5 min 
after stimulation. Arrow indicates areas of GFP-Rap1 up-regulation 
on PM ruffles. PM up-regulation of Rap1 was observed in all control 
cells and validated by measurement of relative fluorescence intensity 
as described in Materials and methods. In contrast, only 16   9% 
and 8   8% (mean   SEM) of NEM-treated and dominant-negative 
Rab11BP (DN Rab11BP) transfected cells, respectively, showed up-
regulation on PM (n   4; P   0.0001 for each condition compared 
with control). (B) COS-1 cells expressing GFP-H-Ras that were serum 
starved and stimulated as in A showed no change in Golgi apparatus 
(arrowhead) or PM (arrow) expression. Images shown are represen-
tative of seven Z slices acquired to compensate for minimal focal 
drift. Bars, 10  M. 
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M-Ras71L has been shown to activate Rap1 via the Rap-
specific GEF, RA GEF 2 (Gao et al., 2001). Whereas
expression of M-Ras71L in COS-1 cells expressing GFP-
RBD
 
RalGDS
 
 failed to induce any redistribution of the reporter
(Fig. 4 B, iv), coexpression of wild-type Rap1 induced a
marked redistribution of the probe to the PM but not intra-
cellular vesicles (Fig. 4 D), demonstrating that, in the pres-
ence of activated M-Ras, Rap1 is activated specifically on
PM. In addition to M-Ras, cAMP has been shown to regu-
late Rap1 in some cells independently of growth factors
via Epac1, a Rap1-specific GEF (Kawasaki et al., 1998). Re-
cently, a novel cAMP analogue that does not activate PKA,
8CPT-2Me-cAMP, was shown to specifically activate Rap1
(Enserink et al., 2002). In contrast to growth factor stimula-
tion, we were unable to detect activation of endogenous or
ectopically expressed Rap1 in COS-1, NIH 3T3, or 293
cells treated with 8CPT-2Me-cAMP using either membrane
recruitment of GFP-RBD
 
RalGDS
 
 in living cells or GST-Ral-
GDS RBD pull-down in cell lysates (unpublished data),
suggesting that Epac1 was not expressed in these cells.
 
Mitogen-stimulated activation of Rap1 occurs only at 
the PM and is dependent on exocytosis
 
The differential membrane localization of GFP-Rap1 (PM and
endosomes) versus GFP-RBD
 
RalGDS
 
 in cells coexpressing Rap1
(PM only) was striking and suggested that under conditions of
growth in serum, the GTP-bound pool of Rap1 is limited to
the PM. Therefore, we sought to use GFP-RBD
 
RalGDS
 
 to study
dynamic changes in Rap1 activation after cell activation.
We have shown that GFP-RBD
 
Raf-1
 
 can report in living cells
dynamic spatio-temporal activation of Ras in response to mi-
togenic stimulation (Chiu et al., 2002). To determine if GFP-
RBD
 
RalGDS
 
 could report similar activation for Rap1, we ex-
 
pressed this probe in COS-1 cells, serum starved the cells, and
then stimulated them with EGF. GFP-RBD
 
RalGDS
 
 was distrib-
uted homogenously throughout the cytosol and nucleoplasm
of 
 
 
 
90% of transfected, serum-starved cells without accumu-
lation on any membrane (Fig. 5 A). Within 5 min of exposure
to EGF, the GFP-RBD
 
RalGDS
 
 reporter was recruited to mem-
brane ruffles by endogenous Rap1 (Fig. 5 A). This recruitment
was transient, reversing by 20 min (Fig. 5 A). When wild-type
Rap1 was overexpressed along with GFP-RBD
 
RalGDS,
 
 a similar,
but more robust, recruitment to membrane ruffles was ob-
served that reversed with the same kinetics (Fig. 5 B) as that
observed with endogenous Rap1 (Fig. 5 A). Similar observa-
tions were made in NIH 3T3 fibroblasts (Fig. 5 C).
To verify that upon stimulation with growth factor, the
RBD of RalGDS can discriminate between activated Rap1
versus Ras, we stimulated COS-1 cells with EGF and immu-
noprecipitated whole cell lysates with either GST-RBD
 
RalGDS
 
or GST-RBD
 
Raf-1
 
. The level of each activated GTPase was
detected by immunoblot using antibodies specific for either
Ras or Rap1. Whereas, GST-RBD
 
RalGDS
 
 detected activated
Rap1 but not Ras, the converse was true for GST-RBD
 
Raf-1
 
(Fig. 5 D). Thus, the RBD of RalGDS is specific for growth
factor–mediated Rap1 activation. We conclude that al-
though Rap1 is expressed on both the PM and internal
membranes, only the pool associated with the PM becomes
GTP bound upon stimulation with EGF. Thus, intracellular
pools of Rap1 differ from those of H-Ras that can be acti-
vated in situ in response to mitogens (Chiu et al., 2002).
To determine if activation of Rap1 on PM requires exocy-
tosis, we analyzed EGF-stimulated recruitment of GFP-
RBD
 
RalGDS
 
 in the presence of NEM or dominant-negative
Rab11BP and found that it was blocked completely by ei-
ther condition (Fig. 6 A). In contrast, inhibition of clathrin-
Figure 4. Rap1 activation in living 
COS-1 cells. (A) COS-1 cells were trans-
fected with GFP-RBDRalGDS and vector (i), 
untagged Rap1 wild type (ii), Rap1V12 
(iii), or Rap1N17 (iv), and cells were 
imaged alive 24 h after transfection under 
conditions of growth in serum. (B) Cos-1 
cells were cotransfected with GFP-
RBDRalGDS (i–v), GFP–RBDRaf-1 (vi–x), and 
either vector (i and vi), untagged Rap1V12 
(ii and vii), untagged H-Ras61L (iii and 
viii), untagged M-Ras71L (iv and ix), or 
untagged R-Ras87L (v and x); serum 
starved; and imaged as in A. Arrowheads 
indicate the Golgi apparatus. (C) COS-1 
cells were cotransfected with GFP–
RBDRalGDS, untagged Rap1 wild type, and 
either vector (i) or untagged Rap1N17 (ii); 
grown in serum; and imaged as in A. (D) 
COS-1 cells were cotransfected with 
GFP–RBDRalGDS, untagged Rap1 wild type, 
and either vector (i) or M-Ras71L (ii); se-
rum starved; and imaged as in A. Arrows 
indicate PM. Bars, 10  M. Results are 
representative of three independent ex-
periments ( 30 cells examined per con-
dition per experiment). 
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mediated endocytosis with dominant-negative epsin had no
effect (Fig. 6 B). Thus, both up-regulation and GTP/GDP
exchange of Rap1 on PM require exocytosis, suggesting that
the two processes are linked.
 
Rap1 is activated at the PM of Jurkat T cells and 
regulates integrin-dependent adhesion in an 
exocytosis-dependent fashion
 
Among the best characterized functions of Rap1 is the reg-
ulation of integrin-mediated adhesion of Jurkat T cells
(Reedquist et al., 2000; Katagiri et al., 2002). Accordingly,
to analyze the role of endosome recycling in Rap1 func-
tion, we used this system. GFP-Rap1 was localized in
Jurkat cells (Fig. 7 A) in a pattern similar to that of
COS-1 and MDCK cells: the wild-type and GTP-bound
(Rap1V12) forms were observed on PM as well as on cyto-
plasmic vesicles and the nuclear envelope, whereas the
nucleotide-free (Rap1N17) form was expressed predomi-
nantly on intracellular membranes. Unstimulated Jurkat
cells were round and exhibited a mixed population of two
distinct patterns of GFP-Rap1 expression where all of the
cells expressed GFP-Rap1 on endomembrane, but the mi-
nority of cells clearly expressed the protein on the PM. Af-
ter stimulation of the TCR by cross-linking CD3, a condi-
tion previously shown to activate Rap1 (Reedquist and
Bos, 1998), the majority of cells were asymmetrical and ex-
hibited a distribution of GFP-Rap1 on both endomem-
Figure 5. Growth factor–stimulated activation of Rap1 in living 
cells. (A) COS-1 cells were transfected with GFP-RBDRalGDS, serum 
starved 24 h after transfection, and imaged alive at the indicated 
times after stimulation with EGF at 37 C. Endomembrane recruitment 
of the probe was not observed in any COS-1 cell. PM recruitment of 
the probe was observed in 60   5% (mean   SEM) of transfected 
cells (n   4). (B) COS-1 or (C) NIH 3T3 cells were cotransfected with 
GFP-RBDRalGDS and untagged Rap1 wild type, serum starved 24 h after 
transfection, and imaged as in A. Arrows indicate GFP-RBDRalGDS 
recruitment to PM. Bars, 10  M. Endomembrane recruitment of the 
probe was observed in no COS-1 or NIH-3T3 cell. PM recruitment 
of the probe was observed in 75   8% and 71   10% (mean   SEM) 
of COS-1 and NIH-3T3 cells, respectively (n   4). (D) COS-1 cells 
were serum starved, and then stimulated with vehicle or 100 ng/ml 
EGF for 5 min. Clarified cell lysates were immunoprecipitated with 
either Sepharose-conjugated GST-RBDRaf-1 and GST-RBDRalGDS 
(top) or anti-Ras and anti-Rap1 polyclonal antisera (bottom). Immu-
noprecipitates were immunoblotted with anti-Ras (left) or anti-Rap1 
(right) mAbs. Results shown are representative of two independent 
experiments.
Figure 6. Activation of Rap1 at the PM is dependent on exocytosis 
but not endocytosis. (A) COS-1 cells were transfected with GFP-
RBDRalGDS alone (top and middle) or with dominant-negative Rab11BP 
(DN Rab11BP; bottom), serum starved 24 h after transfection, and 
stimulated at 37 C with EGF in the absence (top and bottom) or 
presence (middle) of NEM. Endomembrane recruitment of the probe 
was observed in no cell. PM recruitment was observed in 63   14%, 
25   8%, and 29   10% of control, NEM-treated, and DN Rab11BP 
transfected cells (mean   SEM), respectively (n   4; P   0.02 for each 
condition compared with control). (B) COS-1 cells were cotransfected 
with GFP-RBDRalGDS, untagged Rap1 wild type, and dominant-negative 
epsin; serum starved; stimulated with EGF in the presence of Texas 
red–conjugated transferrin; and imaged after 5 min as in A. The dual 
color image shown in the far right panel was acquired 30 min after 
stimulation following removal of excess transferrin. Only the un-
transfected cell to the right accumulated transferrin in endosomes 
(arrowhead). PM recruitment of the probe was observed in 71   17% 
(mean   SEM) of epsin-transfected, EGF-stimulated cells (n   4). 
Arrows indicate GFP-RBDRalGDS recruitment to PM. Bars, 10  M. 
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brane and PM (Fig. 7 C). Despite robust expression of
wild-type GFP-Rap1 on intracellular membranes, GFP-
RBD
 
RalGDS
 
 was recruited in Jurkat cells coexpressing un-
tagged wild-type Rap1 exclusively to the PM (Fig. 7 B, i),
indicating that, like in COS-1 cells, the GTP-bound pool
of wild-type Rap1 is limited to the PM. In contrast, consti-
tutively GTP-bound Rap1V12 recruited GFP-RBD
 
RalGDS
 
to both PM and intracellular membranes (Fig. 7 B, ii). As
in COS-1 cells, nucleotide-free Rap1N17 failed to recruit
GFP-RBD
 
RalGDS
 
 to any membrane (Fig. 7 B, iii).
We confirmed that overexpression of wild-type Rap1 aug-
mented the ability of Jurkat cells to adhere to fibronectin
(Fig. 7 D). Expression of GTP-bound Rap1V12 had an even
greater effect than that of wild-type Rap1. Whereas coex-
pression of dominant-negative Rab11BP had no effect on
the ability of constitutively GTP-bound Rap1V12 to pro-
mote adhesion of Jurkat cells, coexpression of this protein
markedly inhibited wild-type Rap1-stimulated adhesion. To
assess the role of Rap1 and endosomal recycling in a system
where the TCR stimulates inside-out signaling to a specific
integrin, we studied adhesion to ICAM-1–coated surfaces
that is dependent on the activation of LFA-1 (Katagiri et al.,
2002; Fig. 7 E). Although fewer cells adhered to ICAM-1–
coated surfaces than fibronectin-coated surfaces, the LFA–1/
ICAM-1–mediated adhesion could be markedly stimulated
by cross-linking CD3. Whereas overexpression of wild-type
Rap1 slightly augmented adhesion, expression of dominant-
negative Rap1N17 inhibited TCR-stimulated adhesion. Im-
portantly, dominant-negative Rab11BP also inhibited this
process. The results with both fibronectin and ICAM-1 sug-
gest that endosomal recycling is required for regulation by
Rap1 of integrin-mediated adhesion.
 
Discussion
 
Membrane targeting of GTPases that, like Rap1 and Ras,
contain a CAAX motif is determined by posttranslational
processing of the CAAX sequence (Casey et al., 1989),
secondary membrane-targeting sequences adjacent to the
CAAX motif (Hancock et al., 1991), and the capacity to in-
teract after processing with cytosolic chaperones such as
RhoGDI (Michaelson et al., 2001). Unlike the CAA(S/M)
motif of Ras proteins, Rap1 ends in a CAAL motif that be-
comes geranylgeranylated, a modification that is more hy-
drophobic than that of farnesylated Ras proteins (Silvius and
l’Heureux, 1994). The Rap1 CAAL motif is flanked by a rel-
atively strong polybasic region (net charge 
 
 
 
5) similar to
that of K-Ras4B. In this regard, Rap1 is most similar to
Rac1, a geranylgeranylated Rho family GTPase that is tar-
geted to the PM (Michaelson et al., 2001). However, unlike
processed Rac1 that is sequestered in the cytosol by its inter-
action with RhoGDI, Rap1 has no known cytosolic binding
protein and is therefore predicted to have a strong affinity
for the PM.
Despite its Rac1-like membrane-targeting sequence, Rap1
has not been previously localized to the PM of cultured cells.
Originally localized to the Golgi complex (Beranger et al.,
1991), both endogenous and overexpressed Rap1 were later
found to be associated exclusively with late endosomes/lyso-
somes (Pizon et al., 1994). Thus, whereas our localization of
intracellular GFP-tagged Rap1 is consistent with earlier re-
ports, our observation of GFP-Rap1 on the PM of cultured
cells is new but not unexpected. That GFP-Rap1N17 did not
localize, like GFP-Rap1, to the PM argues against a simple
overexpression artifact for the PM localization of the wild-
type protein. Our confirmation by subcellular fractionation,
including affinity purification of biotinylated surface mem-
brane, that endogenous Rap1 is expressed on PM suggests
that the inability to visualize PM-associated Rap1 by indirect
immunofluorescence of fixed and permeabilized cultured
Figure 7. Up-regulation and activation of Rap1 on PM controls 
T cell adhesion. (A) Jurkat T cells were transfected with either GFP-
Rap1 wild type (i), GFP-Rap1V12 (ii), or GFP-Rap1N17 (iii) and 
imaged alive 48 h after transfection and growth in serum. (B) Jurkat 
cells were transfected with GFP-RBDRalGDS and untagged Rap1 wild 
type (i), Rap1V12 (ii), or Rap1N17 (iii) and imaged as in A. Bars, 2  M. 
Results are representative of three independent experiments ( 30 
cells examined per condition per experiment). (C) Jurkat cells were 
transfected with GFP-Rap1, serum starved, and treated with or 
without anti-CD3 antibodies. Cells were scored for unambiguous PM 
expression and the percentage of such cells before and after cross-
linking TCRs was plotted (mean   SEM, n   4). Representative cells 
before (left) and after (right) anti-CD3 treatment are shown as insets. 
Bars, 2 µM. (D) Jurkat cells were transfected as indicated and plated 
on fibronectin-coated multi-well plates 48 h later. (E) Jurkat cells were 
transfected as indicated and plated on ICAM-1–coated multi-well 
plates 48 h later with or without treatment with anti-CD3 antibodies. 
Cells per well (in duplicate) bound to fibronectin (D) or ICAM-1 (E) 
after 1 h were counted and presented as the mean   SEM (n   4).468 The Journal of Cell Biology | Volume 164, Number 3, 2004
cells is a result of low sensitivity of the assay, and that the lo-
calization of overexpressed GFP-Rap1 on the PM reflects the
true subcellular distribution of the GTPase. This view is sup-
ported by the observation that in primary myeloid cells, Rap1
has been localized to the PM (Quinn et al., 1992). In lym-
phoid cells, a recently identified effector of Rap1, RapL, has
been shown to associate with the surface adhesion molecule
LFA-1 and mediate in a Rap1-dependent fashion its relocal-
ization to the leading edge of the cell (Katagiri et al., 2003),
confirming a functional role for Rap1 on the PM.
More intriguing than the PM localization of Rap1 is the
rapid up-regulation of the GTPase on this compartment
that we observed after growth factor stimulation. The rapid-
ity of the increase in GFP-Rap1 surface expression rules out
new protein synthesis as a source. Cytosolic pools of pro-
cessed GFP-Rap1 were not observed, which is consistent
with the absence of a GDI-like binding partner. Thus, the
additional GFP-Rap1 that appeared on the PM is most
likely derived from an intracellular membrane compart-
ment. Indeed, the source of Rap1 that rapidly appears on the
PM of terminally differentiated myeloid cells in response to
inflammatory agonists is a pool associated with two classes of
specialized vesicles known as secondary (or specific) and ter-
tiary granules that serve as intracellular reservoirs of PM
(Maridonneau-Parini and de Gunzburg, 1992; Mollinedo et
al., 1993). Although the cultured epithelial cells and fibro-
blasts used in this work do not contain specialized secretory
granules, the large pool of intracellular Rap1 present on en-
dosomes is a potential source of rapidly mobilizable protein.
The sensitivity of Rap1 surface up-regulation to NEM sug-
gests that membrane fusion events are required, and the in-
hibition by dominant-negative Rab11BP implicates recy-
cling endosomes as the source of additional PM Rap1. Thus,
specialized secretory organelles are not required for the regu-
lation of Rap1 surface expression by exocytosis.
Given the large pool of intracellular Rap1 and the recent
observation that intracellular Ras is activated in situ by
growth factor signaling (Chiu et al., 2002), it was somewhat
surprising to observe Rap1 activation only at the PM. This
suggests that the GEFs that activate Rap1 after EGFR liga-
tion are localized at the PM. EGFR stimulation causes re-
cruitment to the PM of the GEF SOS, which activates sev-
eral Ras-related GTPases including M-Ras (Quilliam et al.,
1999). We observed that GTP-bound M-Ras71L stimulated
activation of Rap1 at the PM. Because activation of M-Ras
recruits to the PM RA GEF 2, a Rap-specific GEF (Gao et
al., 2001), we hypothesize that M-Ras links EGFR stimula-
tion with Rap1 activation at the PM.
The reversibility of Rap1 activation at the PM implicates
GAP activity on this compartment. Indeed, Rap1GAP
was localized to the PM (Polakis et al., 1991). Recently,
Rap1GAP has been shown to be dynamically recruited to the
PM by Gz in NGF-stimulated PC12 cells (Meng and Casey,
2002). Because inactive Rap1 traffics through the endosomal
recycling compartment, the balance of GEFs and GAPs in
this compartment might favor the latter, and endocytosis
may serve as a mechanism of down-regulating Rap1.
The coincidence of both up-regulated GFP-Rap1 and ac-
tivated Rap1 on membrane ruffles lends further support to
the view that the two processes are linked. Exocytosis to the
leading edge of the cell where extending lamellipodia require
rapid expansion of the surface membrane is a well estab-
lished paradigm in cell biology and one that may explain the
appearance of GFP-Rap1 in ruffles. Moreover, the preferen-
tial up-regulation of Rap1 in membrane ruffles suggests that
the GTPase may play a role in actin-based processes such as
cell motility and adhesion. Indeed, Rap1 has been impli-
cated in the regulation of integrin-mediated adhesion in
lymphoid cells downstream of the T cell receptor and of
CD31 (Reedquist et al., 2000). We confirmed the role of
Rap1 in integrin-mediated T cell adhesion and showed that
the Rap1-mediated regulation was sensitive to agents that
block endosome recycling. This observation provides func-
tional evidence for regulation by Rap1 of adhesive events at
the PM and for modulation of that function by exocytosis.
Rap1-regulated LFA-1–dependent adhesion at the ruffling
leading edge of the cell and detachment at the uropod have
recently been shown to depend on a residue in the LFA-1  
chain that is required for receptor internalization and recy-
cling (Tohyama et al., 2003). It is tempting to speculate that
the endosomal compartment storing the intracellular pool of
LFA-1 is the same as the one that contains a mobilizable
pool of Rap1.
Our results differ substantially from those of recent works
that observed Rap1 activation only on internal membranes
(Mochizuki et al., 2001; Ohba et al., 2003). The basis for
this discrepancy is not entirely clear but is undoubtedly re-
lated to the distinct methods applied. Those authors did not
directly measure Rap1 activation but rather used an overex-
pressed chimeric FRET probe to sample, in a spatio-tempo-
ral fashion, the relative balance of GEFs and GAPs active
against the chimera. Unfortunately, the Raichu-Rap1 FRET
probe was not unbiased in its subcellular distribution but
rather incorporated the membrane-targeting sequence of
K-Ras4B, well established to target proteins exclusively to the
PM (Hancock et al., 1990; Choy et al., 1999). Moreover, in
these studies, the spatial resolution of the FRET readout was
relatively low, such that specific subcellular compartments
could not be distinguished and the conclusion that Rap1
was activated on endomembranes was based on a diffuse
perinuclear signal. The ability of PM-targeted Raichu-Rap1
to report Rap1 activation on endomembranes has not been
explained, and a Raichu-Rap1 probe with a native mem-
brane-targeting sequence has not been reported. Interest-
ingly, Raichu-Rap1V12, a K-Ras4B–targeted GAP-resistant
probe with a constitutively high degree of GTP binding, re-
ported activity only at the PM that was surprisingly EGF
sensitive (Ohba et al., 2003), which is consistent with our
results using GFP-RBDRalGDS. However, in our work, each
Rap isoform analyzed was targeted to membranes with its
native hypervariable region, and our fluorescent reporter was
untargeted and thus had unbiased access to the cytosolic
leaflet of all membrane compartments. Most importantly,
GFP-RBDRalGDS proved capable of reporting the spatio-tem-
poral activation of endogenous Rap1.
In summary, our in vivo imaging of Rap1 localization and
activation has provided insight into the dynamic regulation
of Rap1 in response to growth factor stimulation and has
highlighted important differences between Rap1 and Ras.
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growth factor stimulation and pools of Ras on intracellular
compartments are activated in situ (Chiu et al., 2002), Rap1
is up-regulated at the PM in conjunction with its activation
principally on that compartment. Moreover, when up-regu-
lation was blocked, so was Rap1 function. We propose that
localization of Rap1 and Ras to different membrane com-
partments contributes to their distinct cellular functions.
Materials and methods
Plasmids
The full or partial coding sequences of the relevant human cDNAs (Ras
isoforms or mutants thereof, Rap1 or mutants thereof, Raf-1, and Ral GDS)
were amplified by PCR and cloned in frame into the mammalian expres-
sion vectors pEGFP-N1 or pEGFP-C3 (CLONTECH Laboratories, Inc.) or
into pcDNA3.1( )/Neo (Invitrogen) as indicated. Production of GFP-Raf-1
RBD is performed as described previously (Chiu et al., 2002). The Ral GDS
RBD was generated by PCR amplification of a cDNA encoding amino ac-
ids 786–883 of human RalGDS and was inserted in frame with GFP into
the pEGFP-N1 vector. All plasmid constructs were verified by bidirectional
sequencing. Mammalian expression vectors encoding M-Ras71L and
R-Ras87L were obtained from A. Cox (University of North Carolina School
of Medicine, Chapel Hill, NC). Mammalian expression vectors encoding
dominant-negative epsin (DPW domain) and dominant-negative Rab11BP
were provided by P. DeCamilli (Yale University School of Medicine, New
Haven, CN) and D. Sabatini (New York University [NYU] School of Medi-
cine, New York, NY), respectively.
Cell culture and transfection
COS-1, MDCK, and NIH 3T3 cells were maintained in 5% CO2 at 37 C in
DME containing 10% FBS (COS-1 and MDCK) or FCS (NIH 3T3; Colorado
Serum Co.). Jurkat cells were maintained in 5% CO2 at 37 C in RPMI con-
taining 10% FBS. Cells to be examined by fluorescence microscopy were
plated at 2   10
5 per plate into 35-mm dishes containing a glass coverslip-
covered 15-mm cutout (MatTek) and transfected the next day. Transfection
of COS-1, MDCK, and NIH 3T3 cells was performed with SuperFect
®
(QIAGEN) according to the manufacturer’s instructions, and cells were ex-
amined the following day. Transfection of Jurkat cells was performed with
DMRIE-C (QIAGEN), and cells were examined 48 h later. Fluorescent load-
ing of endosomes was accomplished by incubating cells with 5  g/ml of
Texas red–conjugated transferrin (Molecular Probes) for 30 min at 37 C fol-
lowed by removal of the unincorporated probe. Jurkat cells were stimulated
with 5  g/ml of mouse anti–human CD3 and anti–human CD28 (Ancell).
Subcellular fractionation
MDCK cells were grown to 90–95% confluence and washed in ice-cold
PBS before harvesting. Cells were suspended in homogenization buffer
(0.3 M sucrose, 10 mM Tris-HCl, pH 7.5, 10 mM KCl, 1 mM DTT, and
protease inhibitors) and disrupted by ball-bearing homogenizer (12- m
clearance). To remove unbroken cells and nuclei, the homogenate was
centrifuged at 600 g for 5 min. Membrane and soluble fractions of the 600-
g supernatant were separated by centrifugation at 160,000 g for 120 min.
The total membrane pellet was resuspended in 1.35 M sucrose and sepa-
rated by flotation through a discontinuous sucrose density gradient (0.25,
0.90, and 1.35 M) by centrifugation (350,000 g for 120 min). Purified
Golgi membranes were isolated at the interface between the 0.25- and
0.9-M sucrose layers. Endosomes were harvested from the 1.35-M sucrose
layer. A mixed fraction of PM and smooth ER was isolated from the inter-
face between the 0.9- and 1.35-M sucrose layers. PM was further purified
by loading this fraction on top of a linear gradient of 5–20% Optiprep (Ny-
comed) and centrifuging for 18 h at 95,000 g. After centrifugation, PM was
harvested from fractions near the top of the gradient. 50  g of each frac-
tion (determined by BCA assay [Pierce Chemical Co.]) was analyzed by
immunoblot for Na
 /K
  ATPase (rabbit polyclonal 1:500; gift of T. Mori-
moto), EEA-1 (mouse monoclonal 1:2,500; Transduction Laboratories), and
Rap-1 (mouse monoclonal 1:1,000; Transduction Laboratories). Immu-
noreactive proteins were detected using rabbit anti–mouse Ig antisera and
125I-protein A and visualized by phosphorimager (Molecular Dynamics).
Biotinylation surface expression assay
Affinity purification of PMs was performed essentially as described previ-
ously (Mammen et al., 1997). In brief, COS-1 cells were grown to conflu-
ency in 10-cm dishes, rinsed, and incubated for 20 min on ice with 10  g/
ml Sulfo-NHS-biotin in biotinylation buffer (10 mM sodium borate, pH
8.8, and 150 mM NaCl). 10 mM NH4Cl was added to terminate the reac-
tion and cells were scraped into 1 ml of cytosolic lysis buffer (10 mM
Hepes, 10 mM NaCl, 1 mM KCl, 5 mM NaHCO3, 1 mM CaCl2, 0.5 mM
MgCl2, 1 mM PMSF, 100 U/ml aprotinin, and 5 mM EDTA) and incubated
for 5 min on ice. Membranes were disrupted on ice using a Dounce ho-
mogenizer, and nuclei and unbroken cells were pelleted at 1,000 g. Crude
membranes were incubated with immobilized streptavidin for 1 h at RT,
and affinity-purified membranes were pelleted. Purified membranes and
membranes in the unbound fraction were solublized in Laemmli buffer,
boiled, and subjected to SDS-PAGE followed by immunoblot analysis. 50
 g of each fraction (determined by BCA assay) was analyzed by immuno-
blot for Na
 /K
  ATPase (rabbit polyclonal 1:500; gift of T. Morimoto), EEA-1
(mouse monoclonal 1:1,000; Transduction Laboratories), and Rap-1 (rab-
bit polyclonal 1:1,000, gift of J. de Gunzburg, Institut Curie, Paris, France).
Immunoreactive proteins were detected using rabbit anti–mouse Ig anti-
sera and 
125I-protein A and visualized by phosphorimager.
Ras/Rap in vitro activation assays
Detection of activated Ras or Rap1 was performed as described previously
(de Rooij and Bos, 1997). Immunoblot analyses were performed using ei-
ther an anti-panRas mAb (Ras10; Upstate Biotechnology) or an anti-Rap1
mAb (Transduction Laboratories). Proteins were detected using 
125I-protein
A by phosphorimager analysis.
Imaging and stimulation
Cells were examined alive with an inverted laser scanning confocal micro-
scope (model Zeiss 510 LSM; Carl Zeiss MicroImaging, Inc.). TIFF images
were processed with Adobe Photoshop 6.0. For stimulation with mitogens,
the cells in 35-mm MatTek plates were maintained at 37 C using a micro-
incubator (model PDMI-2; Harvard Apparatus). Stimulations were per-
formed by adding 100 ng/ml EGF (COS-1 cells) or 5  g/ml (Jurkat cells) of
mouse anti–human CD3 antibodies (Ancell) to the media while continu-
ously observing selected cells. Stimulations in the presence of NEM were
performed by preincubating cells with 1 mM NEM for 30 min at 37 C be-
fore EGF addition. Jurkat T cells expressing GFP-Rap1 were readily divided
into two populations: one manifesting clear PM fluorescence and one with
only endomembrane fluorescence. Up-regulation of Rap1 on Jurkat cell
PM was measured as the percentage of cells manifesting the former pheno-
type before and after cross-linking CD3. Statistical analysis was performed
on results obtained from a minimum of six cells monitored in each of at
least three independent experiments, and p-values were calculated using a
one-tailed t test.
Cell attachment assay
Adhesion assays using either fibronectin or ICAM-1–coated multi-well
plates were performed as described previously (Katagiri et al., 2002). Re-
combinant ICAM-1 was provided by M. Dustin (NYU School of Medicine).
Adhesion of Jurkat cells was quantified as the number of cells remaining
bound to either fibronectin or ICAM-1 after removal of nonadherent cells
with PBS.
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